Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Target Price at $19.17
Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have been assigned an average rating of “Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have updated their coverage on […]
Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have been assigned an average rating of “Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have updated their coverage on […]
